In MetALD, the co-existence of metabolic risk factors (like obesity and T2DM) and moderate-to-high alcohol consumption creates a synergistic double-hit injury that accelerates disease progression and HCC risk significantly more than either factor alone
The potential risks to the developing fetus, coupled with the evolving hormonal landscape of pregnancy, underscore the importance of individualized decision-making guided by healthcare professionals
Your healthcare provider considers your treatment goals, current health status, medication tolerance, and response to therapy when establishing and adjusting your dosing regimen
Inject semaglutide on the same day each week, at any time of the day, with or without meals
Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine , Massachusetts Medical Society, 2022